Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P970051/S234

Nucleus 24 Cochlear Implant System

Cochlear Americas · Decision date Jul 24, 2025

FDA DECISIONP970051/S234

What did the FDA decide?

FDA records P970051/S234 as a supplement to PMA P970051, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 24, 2025.

FDA approval order statement

automation of the paddle cutting process during implant manufacturing
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ear, Nose, Throat
Decision date
Jul 24, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P970051/S234
Regulatory pathway
PMA supplement
Product code
MCM
Decision code
OK30
Decision date
Jul 24, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, cochlear.

Product code
MCM
FDA device class
3

For the original device and its historical approval scope, see PMA P970051. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P970051 · Original PMA

    NUCLEUS 24 COCHLEAR IMPLANT SYSTEM

  2. P970051/S234 received

    Application receipt date recorded by FDA.

  3. P970051/S234 · FDA decision

    30-Day Notice

  4. P970051/S235 · Related supplement

    Nucleus 24 Cochlear Implant System

  5. P970051/S237 · Related supplement

    Cochlear Nucleus System

  6. P970051/S238 · Related supplement

    Nucleus 24 Cochlear Implant System

  7. P970051/S236 · Related supplement

    Nucleus 24 Cochlear Implant System

  8. P970051/S240 · Related supplement

    NUCLEUS 24 COCHLEAR IMPLANT SYSTEM

  9. P970051/S242 · Related supplement

    Nucleus 24 Cochlear Implant System

  10. P970051/S244 · Related supplement

    Nucleus 24 Cochlear Implant System

Timeline entries are records held by MedtechLedger for P970051. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P970051

Product / regulatory recordCompanyPathwayDecision dateSource
Cochlear AmericasPMA approvalJun 25, 1998FDA
Cochlear AmericasPMA supplementAug 6, 2025FDA
Cochlear AmericasPMA supplementSep 2, 2025FDA
Cochlear AmericasPMA supplementSep 26, 2025FDA
Cochlear AmericasPMA supplementOct 16, 2025FDA
Cochlear AmericasPMA supplementDec 19, 2025FDA
Cochlear AmericasPMA supplementApr 30, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA

Explore the linked device profile

Other records with product code MCM

Product / regulatory recordCompanyPathwayDecision dateSource
Med-El Corp.PMA supplementOct 9, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Advanced BionicsPMA supplementSep 18, 2026FDA
Advanced BionicsPMA supplementSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cochlear Americas

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10350 Park Meadows Dr., Lone Tree, CO, 80124

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records